Canaccord Genuity Group Forecasts Strong Price Appreciation for Vitalhub (TSE:VHI) Stock

Vitalhub (TSE:VHI) had its target price boosted by equities researchers at Canaccord Genuity Group from C$12.00 to C$12.50 in a research note issued on Thursday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price points to a potential upside of 12.31% from the stock’s current price.

A number of other equities analysts also recently issued reports on VHI. Cormark increased their price target on Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a research report on Wednesday, October 2nd. TD Securities raised shares of Vitalhub to a “strong-buy” rating in a research note on Monday, November 25th. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Vitalhub currently has an average rating of “Buy” and an average price target of C$10.05.

Vitalhub Stock Performance

Vitalhub stock opened at C$11.13 on Thursday. The company has a market capitalization of C$565.96 million, a PE ratio of 101.18, a P/E/G ratio of 1.18 and a beta of 1.26. The company has a 50 day moving average price of C$11.11 and a 200-day moving average price of C$9.38. Vitalhub has a fifty-two week low of C$4.00 and a fifty-two week high of C$12.09.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.